Simshabs Capital Partners, Ltd.
Rafi Weiss Agrees to Settlement With Regard to Articles Posted on the Web
Immunovaccine Inc.
Immunovaccine Receives Final Approval to Graduate to TSX
Shares to Begin Trading on TSX at Opening of Market on November 26
Contact Information: Immunovaccine Inc.Dr. Marc MansourChief Executive Officer(902) 492-1819mmansour@imvaccine.comVida Strategic Partners (media)Tim Brons(415) 675-7402tbrons@vidasp.com]]>